Messenger RNA (mRNA) vaccines may be the hottest thing in science now, as they helped turn the tide against COVID-19.

Much less is known about how the activity of insulin-producing cells and consequently the secretion of insulin is controlled.

The results of this study are in stark contrast to anything we’ve seen before in pancreatic cancer, said Ben Stanger, MD, PhD.

Vaccination with senescent cells significantly reduces the development of tumours in experimental models of melanoma and pancreatic cancer.

New study shows a major preventive effect from resistant starch, found in a range of foods such as oats and slightly green bananas.

The key to mRNA vaccines appears to be proteins in the pancreatic tumors, which alert the immune system to keep the cancer at bay.

Researchers have developed an oral medication to treat diabetes that controls insulin levels while simultaneously reversing disease effects.

A small molecule inhibitor that attacks the difficult to target, cancer-causing gene mutation KRAS, found in nearly 30 % of all human tumors

Vaccination with senescent cells significantly reduces the development of tumours in experimental models of melanoma and pancreatic cancer.

The key to these vaccines appears to be neoantigens in the pancreatic tumors, which alert the immune system to keep the cancer at bay.

Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer.

Researchers have developed an oral medication to treat diabetes that controls insulin levels while simultaneously reversing the disease.

Vaccination with senescent cells significantly reduces the development of tumours in experimental models of melanoma and pancreatic cancer.

The key to these vaccines appears to be proteins in the pancreatic tumors, called neoantigens, which keep the cancer at bay.

Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer.

Researchers have developed an oral medication to treat diabetes that controls insulin levels while reversing its inflammatory effects.

With a five-year survival rate of only 9%, incidence of the most common type, pancreatic ductal adenocarcinoma (PDAC), is growing.

Researchers developed an oral medication to treat diabetes that controls insulin levels while simultaneously reversing inflammation.

Yale researchers have developed an oral medication to treat diabetes that controls insulin levels while simultaneously reversing the disease

Implantable devices that release insulin into the body hold promise as an alternative way to treat diabetes without insulin injections.